Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response.

Area of Science:

• Immunology
• Biotechnology
• Materials Science

Background:

• Dendritic cells (DCs) are crucial antigen-presenting cells (APCs) that activate naive T cells.
• T cell activation requires interaction between ICAM-1 on DCs and LFA-1 on T cells.
• Inhibiting this interaction is a potential strategy for modulating immune responses.

Purpose of the Study:

• To investigate nanoparticles as inhibitors of T cell conjugation to DCs by targeting the LFA-1/ICAM-1 interaction.
• To compare the efficacy of peptide-functionalized nanoparticles with free peptides and antibodies.

Main Methods:

• Primary DCs were primed and treated with peptides (LABL for ICAM-1, cIBR for LFA-1) or these peptides conjugated to poly(dl-lactic-co-glycolic acid) nanoparticles (NPs).
• Inhibition of T cell conjugation to DCs was measured.
• T cell proliferation and cytokine production were assessed in co-cultures.

Main Results:

• LABL-NPs and cIBR-NPs significantly inhibited T cell conjugation to DCs more effectively than free peptides or antibodies.
• DCs treated with cIBR-NPs stimulated T cell proliferation, while LABL-NP treated DCs did not.
• Nanoparticles altered cytokine production in DC-T cell co-cultures.

Conclusions:

• Polymeric nanoparticles functionalized with peptides targeting ICAM-1 or LFA-1 are potent inhibitors of T cell conjugation to DCs.
• These targeted nanoparticles represent a promising tool for precisely modulating T cell responses and cytokine profiles.